United States In Vitro Diagnostics Market, Forecast by IVD Segments, Products, Companies
In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. In Vitro Diagnostics has proven itself to be the best diagnostic procedures in managing the chronic diseases. IVDs help in the early detection of patient’s health condition and risk associated with it, creating new opportunities for the early intervention and prevention. United States In-Vitro Diagnostics (IVD) Market is the largest IVD market across the world and is also the leading consumer of the IVD market. IVD market increasingly is subject to demands for improved diagnosis and quality test results of patient’s ailments. In Vitro Diagnostics help in responding such demands by enabling accurate detection of diseases and health risks at the earlier stages, aid in improved treatment and disease management, further diminishing the subsequent health risks and their associated cost. United States In Vitro Diagnostics (IVD) market is expected to be more than US$ 35 Billion by the end of year 2024.
In the United States, some of the common diagnostic tests conducted include cholesterol level tests, blood sugar tests, HIV tests, pap tests, tests for infectious diseases, hCG (pregnancy) tests and substance abuse tests. Some of the major factors stimulating the growth of the United States IVD market include a high incidence of chronic diseases, increasing preference for Point of Care (POC) diagnostics, technological advancements in the field of diagnostics and increasing awareness and acceptance regarding personalized medicine. In addition; government favorable healthcare policy, better healthcare infrastructure and increasing consumer’s healthcare expenditure for seeking quality healthcare further helps United States IVD Market to grow effortlessly over the forecast period.
Renub Research report titled “United States In Vitro Diagnostics Market, IVD Segments (Clinical Chemistry, Microbiology -ID/AST, Microbiology – Molecular, POC – Professional, POC - OTC Diabetes, POC – Others, Immunoassay – Infectious, Immunoassay – Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry), Products (Services, Software, Reagents, Instruments) Regions (South, West, Midwest, North East), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of United States In Vitro Diagnostics (IVD) Market.
Point of Care Testing market dominates United States In-Vitro Diagnostics (IVD) Market
United States In Vitro Diagnostics (IVD) Market is segmented into Clinical chemistry, Microbiology -ID/AST, Microbiology – Molecular, POC – Professional, POC - OTC Diabetes, POC – Others, Immunoassay – Infectious, Immunoassay – Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry. Point of care testing market dominates the United States In-Vitro Diagnostics (IVD) market.
Instruments and Reagents are leading Products in the United States In-Vitro Diagnostics (IVD) Market
On the basis of products, United States In-Vitro Diagnostics (IVD) market is segmented into service, software, instruments and reagents. Instruments and reagents are top two leading products in the United States In-Vitro Diagnostics (IVD) market.
South Region holds impressive share in the United States In-Vitro Diagnostics (IVD) Market
In this report, we have categorized the United States In-Vitro Diagnostics (IVD) market into four regions; South, West, Midwest, North East. It is anticipated that South and West regions plays the significant role in the United States In-Vitro Diagnostics (IVD) market during the forecast period of 2019-2024.
Company Analysis
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies operating in the In-Vitro Diagnostics segment globally. All the companies have been studied from three points
1. Clinical chemistry
2. Microbiology -ID/AST
3. Microbiology – Molecular
4. POC – Professional
5. POC - OTC Diabetes
6. POC – Others
7. Immunoassay – Infectious
8. Immunoassay – Others
9. Urinalysis
10. Molecular - Non Infectious
11. Coagulation
12. Histology
13. Hematology
14. Blood Testing and Typing
15. Flow Cytometry
By Products - United States In-Vitro Diagnostics (IVD) Market
In the United States, some of the common diagnostic tests conducted include cholesterol level tests, blood sugar tests, HIV tests, pap tests, tests for infectious diseases, hCG (pregnancy) tests and substance abuse tests. Some of the major factors stimulating the growth of the United States IVD market include a high incidence of chronic diseases, increasing preference for Point of Care (POC) diagnostics, technological advancements in the field of diagnostics and increasing awareness and acceptance regarding personalized medicine. In addition; government favorable healthcare policy, better healthcare infrastructure and increasing consumer’s healthcare expenditure for seeking quality healthcare further helps United States IVD Market to grow effortlessly over the forecast period.
Renub Research report titled “United States In Vitro Diagnostics Market, IVD Segments (Clinical Chemistry, Microbiology -ID/AST, Microbiology – Molecular, POC – Professional, POC - OTC Diabetes, POC – Others, Immunoassay – Infectious, Immunoassay – Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry), Products (Services, Software, Reagents, Instruments) Regions (South, West, Midwest, North East), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of United States In Vitro Diagnostics (IVD) Market.
Point of Care Testing market dominates United States In-Vitro Diagnostics (IVD) Market
United States In Vitro Diagnostics (IVD) Market is segmented into Clinical chemistry, Microbiology -ID/AST, Microbiology – Molecular, POC – Professional, POC - OTC Diabetes, POC – Others, Immunoassay – Infectious, Immunoassay – Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry. Point of care testing market dominates the United States In-Vitro Diagnostics (IVD) market.
Instruments and Reagents are leading Products in the United States In-Vitro Diagnostics (IVD) Market
On the basis of products, United States In-Vitro Diagnostics (IVD) market is segmented into service, software, instruments and reagents. Instruments and reagents are top two leading products in the United States In-Vitro Diagnostics (IVD) market.
South Region holds impressive share in the United States In-Vitro Diagnostics (IVD) Market
In this report, we have categorized the United States In-Vitro Diagnostics (IVD) market into four regions; South, West, Midwest, North East. It is anticipated that South and West regions plays the significant role in the United States In-Vitro Diagnostics (IVD) market during the forecast period of 2019-2024.
Company Analysis
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies operating in the In-Vitro Diagnostics segment globally. All the companies have been studied from three points
- Overview
- Initiatives & Recent Developments
- Sales
1. Clinical chemistry
2. Microbiology -ID/AST
3. Microbiology – Molecular
4. POC – Professional
5. POC - OTC Diabetes
6. POC – Others
7. Immunoassay – Infectious
8. Immunoassay – Others
9. Urinalysis
10. Molecular - Non Infectious
11. Coagulation
12. Histology
13. Hematology
14. Blood Testing and Typing
15. Flow Cytometry
By Products - United States In-Vitro Diagnostics (IVD) Market
- Services
- Software
- Reagents
- Instruments
- South
- West
- Midwest
- North East
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Sysmex Corporation
1. INTRODUCTION
2. RESEARCH & METHODOLOGY
3. UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
4. MARKET SHARE – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) ANALYSIS
4.1 By Segments
4.2 By Products
4.3 By Regions
5. SEGMENTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
5.1 Clinical Chemistry
5.2 Microbiology -ID/AST
5.3 Microbiology – Molecular
5.4 POC – Professional
5.5 POC - OTC Diabetes
5.6 POC – Others
5.7 Immunoassay – Infectious
5.8 Immunoassay – Others
5.9 Urinalysis
5.10 Molecular - Non Infectious
5.11 Coagulation
5.12 Histology
5.13 Hematology
5.14 Blood Testing and Typing
5.15 Flow Cytometry
6. PRODUCTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
6.1 Services
6.2 Software
6.3 Reagents
6.4 Instruments
7. REGIONS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
7.1 South
7.2 West
7.3 Midwest
7.4 North East
8. MARKET DYNAMICS
8.1 Growth Drivers
8.1.1 Growth in Chronic & Infectious Disease
8.1.2 Technological Advances
8.1.3 Aging Population
8.2 Challenges
8.2.1 Cumbersome Reimbursement Procedure
8.2.2 Shortage of Lab Technicians
9. COMPANY ANALYSIS
9.1 Roche Diagnostics
9.1.1 Overview
9.1.2 Initiatives & Recent Developments
9.1.3 Sales
9.2 Abbott Diagnostics
9.2.1 Overview
9.2.2 Initiatives & Recent Developments
9.2.3 Sales
9.3 Siemens Healthineers
9.3.1 Overview
9.3.2 Initiatives & Recent Developments
9.3.3 Sales
9.4 Danaher Corporation
9.4.1 Overview
9.4.2 Initiatives & Recent Developments
9.4.3 Sales
9.5 Thermo Fisher Scientific
9.5.1 Overview
9.5.2 Initiatives & Recent Developments
9.5.3 Sales
9.6 Sysmex Corporation
9.6.1 Overview
9.6.2 Initiatives & Recent Developments
9.6.3 Sales
2. RESEARCH & METHODOLOGY
3. UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
4. MARKET SHARE – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) ANALYSIS
4.1 By Segments
4.2 By Products
4.3 By Regions
5. SEGMENTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
5.1 Clinical Chemistry
5.2 Microbiology -ID/AST
5.3 Microbiology – Molecular
5.4 POC – Professional
5.5 POC - OTC Diabetes
5.6 POC – Others
5.7 Immunoassay – Infectious
5.8 Immunoassay – Others
5.9 Urinalysis
5.10 Molecular - Non Infectious
5.11 Coagulation
5.12 Histology
5.13 Hematology
5.14 Blood Testing and Typing
5.15 Flow Cytometry
6. PRODUCTS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
6.1 Services
6.2 Software
6.3 Reagents
6.4 Instruments
7. REGIONS – UNITED STATES IN-VITRO DIAGNOSTICS (IVD) MARKET
7.1 South
7.2 West
7.3 Midwest
7.4 North East
8. MARKET DYNAMICS
8.1 Growth Drivers
8.1.1 Growth in Chronic & Infectious Disease
8.1.2 Technological Advances
8.1.3 Aging Population
8.2 Challenges
8.2.1 Cumbersome Reimbursement Procedure
8.2.2 Shortage of Lab Technicians
9. COMPANY ANALYSIS
9.1 Roche Diagnostics
9.1.1 Overview
9.1.2 Initiatives & Recent Developments
9.1.3 Sales
9.2 Abbott Diagnostics
9.2.1 Overview
9.2.2 Initiatives & Recent Developments
9.2.3 Sales
9.3 Siemens Healthineers
9.3.1 Overview
9.3.2 Initiatives & Recent Developments
9.3.3 Sales
9.4 Danaher Corporation
9.4.1 Overview
9.4.2 Initiatives & Recent Developments
9.4.3 Sales
9.5 Thermo Fisher Scientific
9.5.1 Overview
9.5.2 Initiatives & Recent Developments
9.5.3 Sales
9.6 Sysmex Corporation
9.6.1 Overview
9.6.2 Initiatives & Recent Developments
9.6.3 Sales
LIST OF FIGURES:
Figure-01: United States IVD Market (Million US$), 2013 – 2018
Figure-02: Forecast for United States IVD Market (Million US$), 2019 – 2024
Figure-03: United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2013 – 2018
Figure-04: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2019 – 2024
Figure-05: United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2013 – 2018
Figure-06: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2019 – 2024
Figure-07: United States In-Vitro Diagnostics (IVD) Market Share (%) by Regions, 2019 – 2024
Figure-08: Forecast for Delivery Models - India Online Food Delivery Market Share (%) 2019 – 2023
Figure-09: United States – In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2013 – 2018
Figure-10: United States – Forecast for In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2019 – 2024
Figure-11: United States – In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2013 – 2018
Figure-12: United States – Forecast for In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2019 – 2024
Figure-13: United States – In-Vitro Diagnostics Market by Microbiology – Molecular (Million US$), 2013 – 2018
Figure-14: United States – Forecast for In-Vitro Diagnostics Market by Microbiology – Molecular (Million US$), 2019 – 2024
Figure-15: United States – In-Vitro Diagnostics Market by POC – Professional (Million US$), 2013 – 2018
Figure-16: United States – Forecast for In-Vitro Diagnostics Market by POC – Professional (Million US$), 2019 – 2024
Figure-17: United States – In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2013 – 2018
Figure-18: United States – Forecast for In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2019 – 2024
Figure-19: United States – In-Vitro Diagnostics Market by POC – Others (Million US$), 2013 – 2018
Figure-20: United States – Forecast for In-Vitro Diagnostics Market by POC – Others (Million US$), 2019 – 2024
Figure-21: United States – In-Vitro Diagnostics Market by Immunoassay – Infectious (Million US$), 2013 – 2018
Figure-22: United States – Forecast for In-Vitro Diagnostics Market by Immunoassay – Infectious (Million US$), 2019 – 2024
Figure-23: United States – In-Vitro Diagnostics Market by Immunoassay – Others (Million US$), 2013 – 2018
Figure-24: United States – Forecast for In-Vitro Diagnostics Market by Immunoassay – Others (Million US$), 2019 – 2024
Figure-25: United States – In-Vitro Diagnostics Market by Urinalysis (Million US$), 2013 – 2018
Figure-26: United States – Forecast for In-Vitro Diagnostics Market by Urinalysis (Million US$), 2019 – 2024
Figure-27: United States – In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2013 – 2018
Figure-28: United States – Forecast for In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2019 – 2024
Figure-29: United States – In-Vitro Diagnostics Market by Coagulation (Million US$), 2013 – 2018
Figure-30: United States – Forecast for In-Vitro Diagnostics Market by Coagulation (Million US$), 2019 – 2024
Figure-31: United States – In-Vitro Diagnostics Market by Histology (Million US$), 2013 – 2018
Figure-32: United States – Forecast for In-Vitro Diagnostics Market by Histology (Million US$), 2019 – 2024
Figure-33: United States – In-Vitro Diagnostics Market by Hematology (Million US$), 2013 – 2018
Figure-34: Forecast for Online Food Delivery Market By Hematology (Million US$), 2019 – 2025
Figure-35: United States – In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2013 – 2018
Figure-36: United States – Forecast for In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2019 – 2024
Figure-37: United States – In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2013 – 2018
Figure-38: United States – Forecast for In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2019 – 2024
Figure-39: United States In-Vitro Diagnostics Products Market by Services (Million US$), 2013 – 2018
Figure-40: United States – Forecast for In-Vitro Diagnostics Products Market by Services (Million US$), 2019 – 2024
Figure-41: United States In-Vitro Diagnostics Products Market by Software (Million US$), 2013 – 2018
Figure-42: United States – Forecast for In-Vitro Diagnostics Products Market by Software (Million US$), 2019 – 2024
Figure-43: United States In-Vitro Diagnostics Products Market by Reagents (Million US$), 2013 – 2018
Figure-44: United States – Forecast for In-Vitro Diagnostics Products Market by Reagents (Million US$), 2019 – 2024
Figure-45: United States In-Vitro Diagnostics Products Market by Instruments (Million US$), 2013 – 2018
Figure-46: United States – Forecast for In-Vitro Diagnostics Products Market by Instruments (Million US$), 2019 – 2024
Figure-47: United States In-Vitro Diagnostics Market by South Regions (Million US$), 2013 – 2018
Figure-48: United States – Forecast for In-Vitro Diagnostics Market by South Regions (Million US$), 2019 – 2024
Figure-49: United States In-Vitro Diagnostics Market by West Regions (Million US$), 2013 – 2018
Figure-50: United States – Forecast for In-Vitro Diagnostics Market by West Regions (Million US$), 2019 – 2024
Figure-51: United States In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2013 – 2018
Figure-52: United States – Forecast for In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2019 – 2024
Figure-53: United States In-Vitro Diagnostics Market by North East Regions (Million US$), 2013 – 2018
Figure-54: United States – Forecast for In-Vitro Diagnostics Market by North East Regions (Million US$), 2019 – 2024
Figure-55: Prevalence of Chronic Disease in United States (1995 - 2030)
Figure-56: Global – Population aged 65 & Over, (in Millions), 2015, 2030 & 2050
Figure-57: Roche Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-58: Roche Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-59: Abbott Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-60: Abbott Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-61: Siemens Healthineers – Global Diagnostics Sales (Million US$), 2015 – 2018
Figure-62: Siemens Healthineers – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-63: Danaher Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-64: Danaher Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-65: Thermo Fisher Scientific – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-66: Thermo Fisher Scientific – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-67: Sysmex Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-68: Sysmex Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-01: United States IVD Market (Million US$), 2013 – 2018
Figure-02: Forecast for United States IVD Market (Million US$), 2019 – 2024
Figure-03: United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2013 – 2018
Figure-04: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2019 – 2024
Figure-05: United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2013 – 2018
Figure-06: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2019 – 2024
Figure-07: United States In-Vitro Diagnostics (IVD) Market Share (%) by Regions, 2019 – 2024
Figure-08: Forecast for Delivery Models - India Online Food Delivery Market Share (%) 2019 – 2023
Figure-09: United States – In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2013 – 2018
Figure-10: United States – Forecast for In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2019 – 2024
Figure-11: United States – In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2013 – 2018
Figure-12: United States – Forecast for In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2019 – 2024
Figure-13: United States – In-Vitro Diagnostics Market by Microbiology – Molecular (Million US$), 2013 – 2018
Figure-14: United States – Forecast for In-Vitro Diagnostics Market by Microbiology – Molecular (Million US$), 2019 – 2024
Figure-15: United States – In-Vitro Diagnostics Market by POC – Professional (Million US$), 2013 – 2018
Figure-16: United States – Forecast for In-Vitro Diagnostics Market by POC – Professional (Million US$), 2019 – 2024
Figure-17: United States – In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2013 – 2018
Figure-18: United States – Forecast for In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2019 – 2024
Figure-19: United States – In-Vitro Diagnostics Market by POC – Others (Million US$), 2013 – 2018
Figure-20: United States – Forecast for In-Vitro Diagnostics Market by POC – Others (Million US$), 2019 – 2024
Figure-21: United States – In-Vitro Diagnostics Market by Immunoassay – Infectious (Million US$), 2013 – 2018
Figure-22: United States – Forecast for In-Vitro Diagnostics Market by Immunoassay – Infectious (Million US$), 2019 – 2024
Figure-23: United States – In-Vitro Diagnostics Market by Immunoassay – Others (Million US$), 2013 – 2018
Figure-24: United States – Forecast for In-Vitro Diagnostics Market by Immunoassay – Others (Million US$), 2019 – 2024
Figure-25: United States – In-Vitro Diagnostics Market by Urinalysis (Million US$), 2013 – 2018
Figure-26: United States – Forecast for In-Vitro Diagnostics Market by Urinalysis (Million US$), 2019 – 2024
Figure-27: United States – In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2013 – 2018
Figure-28: United States – Forecast for In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2019 – 2024
Figure-29: United States – In-Vitro Diagnostics Market by Coagulation (Million US$), 2013 – 2018
Figure-30: United States – Forecast for In-Vitro Diagnostics Market by Coagulation (Million US$), 2019 – 2024
Figure-31: United States – In-Vitro Diagnostics Market by Histology (Million US$), 2013 – 2018
Figure-32: United States – Forecast for In-Vitro Diagnostics Market by Histology (Million US$), 2019 – 2024
Figure-33: United States – In-Vitro Diagnostics Market by Hematology (Million US$), 2013 – 2018
Figure-34: Forecast for Online Food Delivery Market By Hematology (Million US$), 2019 – 2025
Figure-35: United States – In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2013 – 2018
Figure-36: United States – Forecast for In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2019 – 2024
Figure-37: United States – In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2013 – 2018
Figure-38: United States – Forecast for In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2019 – 2024
Figure-39: United States In-Vitro Diagnostics Products Market by Services (Million US$), 2013 – 2018
Figure-40: United States – Forecast for In-Vitro Diagnostics Products Market by Services (Million US$), 2019 – 2024
Figure-41: United States In-Vitro Diagnostics Products Market by Software (Million US$), 2013 – 2018
Figure-42: United States – Forecast for In-Vitro Diagnostics Products Market by Software (Million US$), 2019 – 2024
Figure-43: United States In-Vitro Diagnostics Products Market by Reagents (Million US$), 2013 – 2018
Figure-44: United States – Forecast for In-Vitro Diagnostics Products Market by Reagents (Million US$), 2019 – 2024
Figure-45: United States In-Vitro Diagnostics Products Market by Instruments (Million US$), 2013 – 2018
Figure-46: United States – Forecast for In-Vitro Diagnostics Products Market by Instruments (Million US$), 2019 – 2024
Figure-47: United States In-Vitro Diagnostics Market by South Regions (Million US$), 2013 – 2018
Figure-48: United States – Forecast for In-Vitro Diagnostics Market by South Regions (Million US$), 2019 – 2024
Figure-49: United States In-Vitro Diagnostics Market by West Regions (Million US$), 2013 – 2018
Figure-50: United States – Forecast for In-Vitro Diagnostics Market by West Regions (Million US$), 2019 – 2024
Figure-51: United States In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2013 – 2018
Figure-52: United States – Forecast for In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2019 – 2024
Figure-53: United States In-Vitro Diagnostics Market by North East Regions (Million US$), 2013 – 2018
Figure-54: United States – Forecast for In-Vitro Diagnostics Market by North East Regions (Million US$), 2019 – 2024
Figure-55: Prevalence of Chronic Disease in United States (1995 - 2030)
Figure-56: Global – Population aged 65 & Over, (in Millions), 2015, 2030 & 2050
Figure-57: Roche Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-58: Roche Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-59: Abbott Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-60: Abbott Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-61: Siemens Healthineers – Global Diagnostics Sales (Million US$), 2015 – 2018
Figure-62: Siemens Healthineers – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-63: Danaher Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-64: Danaher Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-65: Thermo Fisher Scientific – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-66: Thermo Fisher Scientific – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-67: Sysmex Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-68: Sysmex Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
